Abstract
The authors' findings say about compatibility of clinical responses to naftidrofuril (daily dose 600 mg) and pentoxifillin (daily dose 600 mg) in patients with atherosclerosis of the lower limb artery and intermittent claudication stage II. Both the drugs had minimal effects on coagulant and fibrinolytic systems and platelet aggregation.
Publication types
-
Comparative Study
-
English Abstract
MeSH terms
-
Drug Evaluation
-
Female
-
Fibrinolysis / drug effects
-
Hemostasis / drug effects
-
Humans
-
Intermittent Claudication / blood
-
Intermittent Claudication / drug therapy*
-
Male
-
Middle Aged
-
Nafronyl / therapeutic use*
-
Pentoxifylline / therapeutic use
-
Serotonin Antagonists / therapeutic use*
-
Vasodilator Agents / therapeutic use
Substances
-
Serotonin Antagonists
-
Vasodilator Agents
-
Nafronyl
-
Pentoxifylline